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INTRODUCTION:  Cancer  in  pregnancy  is  rare  and  hepatocellular  carcinoma  (HCC)  during  pregnancy  is
even  rarer.  Due  to limited  experience,  management  of these  patients  remains  challenging.
PRESENTATION OF  CASE:  A 33-year  old  pregnant  lady  presented  with  HCC  at  28 weeks  of gestation.  She
underwent  synchronous  cesarean  section  and  right  hepatectomy  at 32  weeks  of  gestation.  The  post-
operative  course  was  uneventful.  She  was  discharged  home  on day  10 after  surgery.  Histolopathology
conﬁrmed  HCC.  The  surgical  resection  margins  were  clear.  At  a  follow-up  of  3 months  after  surgery,  theepatectomy
regnancy
esarean  section
mother  was  disease  free  and  the  infant  was well.
DISCUSSION: HCC  during  pregnancy  is  extremely  rare.  The  experience  in  its management  and  outcomes
are  lacking.  In managing  any  patient  diagnosed  with  a malignant  neoplasm  in  pregnancy,  both  the  mother
and  the  fetus  have  to be  considered.
CONCLUSION: With  adequate  preoperative  assessment  and  a  good  management  strategy,  good  results
can  be obtained  for  both  the mother  and  the  baby  for a pregnant  patient  with  HCC.
gical © 2012 Sur
. Introduction
Cancer in pregnancy is rare. The commonly quoted incidence,
hich is based on a 7-year study involving 11,087 cases, is 9.92
ases of cancer per 10,000 pregnancies.1 HCC during pregnancy is so
are that only less than 50 cases have been reported worldwide. The
arity of HCC presenting during pregnancy is due to a combination
f three factors: the male predominance of HCC, rarity of HCC in
eproductive age, and decreased fertility in women with advanced
irrhosis.2,3 HCC in pregnancy is believed to have a worse prognosis
han non-pregnant women.3,4 In the majority of reported cases,
regnancy was terminated when cancer was diagnosed.
We  reported a case of HCC in a pregnant lady who  received syn-
hronous right hepatectomy and cesarean section with good results
o both the mother and the baby.
. Presentation of caseA 33-year-old female, at the third trimester of pregnancy, was
iagnosed to have chronic hepatitis B at a premarital checkup 1 year
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ago. Regular prenatal examination at 28 weeks pregnancy showed
abnormal liver function with a bilirubin level 2.9 mol/L, alanine
amino transaminase (ALT) 71 IU/L and aspartate aminotransferase
(AST) 88 IU/L. A subsequent alpha-feto protein (AFP) was 973 g/L,
and ultrasound showed of a huge mass (155 mm ×134 mm)  in
the right liver. Her hepatitis B status showed HBsAg (+), Anti-HBe
(+), Anti-HBc (+), HBV-DNA: 6.29 ×10e4 copies/mL. Magnetic reso-
nance imaging (MRI) scan conﬁrmed a huge lesion in the right liver,
15 cm × 15 cm × 14 cm,  showing typical features of HCC and there
was another nodule in segment 4 (size, 2.0 cm)  showing features of
a metastatic lesion from the HCC (Fig. 1).
Ultrasound also showed intrauterine pregnancy with a 30 weeks
normal fetus. The estimated weight of the fetus was 1478 ± 216 g.
The plan was  to carry out a synchronous right hepatectomy and
cesarean section when the fetus had reached to an acceptable
weight. After two  weeks of wait, ultrasound estimated the fetal
size to be equivalent to a 31 weeks normal fetus, with an estimated
weight of 1713 ± 250 g.
On  the date of the operation, the liver function was: total
bilirubin, 3.5 mol/L; albumin, 33.7 g/L; ALT, 58 IU/L; AST, 102 IU/L;
alkaline phosphatase(ALP) 97 IU/L and indocyanine green retention
rate at 15 min  (ICG-R15) 3.4%. Cesarean section was performed at
32 gestational week. A normal male infant with a body weight of
1.8 kg was delivered. This was followed immediately by right hep-
atectomy using the anterior approach and wedge resection of the
Open access under CC BY-NC-ND license.segment 4 nodule. No vascular inﬂow occlusion during liver tran-
section was  used. The liver was  not cirrhotic. The intraoperative
blood loss was  1000 mL.  The operation took 260 min. The resected
specimens showed a 15 cm tumor in the right liver and a 2.0 cm
 BY-NC-ND license.
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Fig. 1. MRI  showed a 15 cm × 15 cm × 14 cm HCC at the right liver with contrast enhancem
(Fig. 1b).
Fig. 2. Intraoperative photograph of the liver tumor.
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fig. 3. Liver remnant after right hepatectomy and wedge resection of a segment 4
odule.
umor in segment 4 (Figs. 2 and 3). The baby weighted 1.8 kg and
e stayed in the neonatal units for 7 days. The post-operative course
as uneventful. The patient was discharged home on operative day
0.
Histolopathology showed a moderately differentiated HCC. The
egment 4 nodule was a focal nodular hyperplasia (FNH). The surgi-
al margins were clear. Additionally, there was no malignant cell in
he placenta or the umbilical cord. Pathological TNM grading of the
umor was T1N0M0. 3 months after surgery, she remained disease
ree. Both mother and infant were well.ent in the arterial phase (Fig. 1a) and portal venous wash out in the venous phase
3.  Discussion
HCC during pregnancy is extremely rare. The experience in its
management and outcomes are lacking. In managing any patient
diagnosed with a malignant neoplasm in pregnancy, both the
mother and the fetus have to be considered. For patients who are
in the ﬁrst trimester of pregnancy, if the tumor is aggressive, ther-
apeutic abortion should be offered so that treatment can be started
on the mother as soon as possible. For patients in the second or third
trimester, a thorough discussion with the patient on management
plan and a multidisciplinary approach among surgeons, obstetri-
cians and radiologists should be adopted. In our patient, the large
size of HCC added to the complexity of management. We  decided to
wait for 4 weeks until it was safe to carry out synchronous cesarean
section and right hepatectomy for both the fetus and the mother
with good post-operative outcomes.
Pregnancy may  have an adverse effect on the prognosis of some
tumors, although this is still controversial. A hypothesis puts the
blame on elevated levels of sex hormones.6 In 1995, Lau et al.
reported 5 cases and analyzed an additional 23 cases of HCC in
pregnancy reported in the literature. Only 3 mothers received liver
resection.4 Live infants were delivered in 57% of cases, but the
maternal outcome was  grave. Twenty mothers died of various rea-
sons within periods as short as days. Only two patients survived
for up to a year after diagnosis. The median survival was shorter
than patients who  were not pregnant. In 2011, Choi et al. reported
4 cases and analyzed an additional 44 cases of HCC in pregnancy
reported in the literature. Only 16 mothers got a chance of liver
resection.5 The overall 6-month and 1-, 2-, and 3-year survival rates
were 50, 29.5, 18.2, and 13.6%, respectively. The median survivals of
the groups before and during/after 1995 were 18 and 25.5 months,
respectively. The morbidity and mortality of HCC during pregnancy
has improved over time, as diagnoses tended to be made earlier and
patients tended to receive surgical and other treatments.
In  conclusion, with adequate preoperative assessment and man-
agement, curative treatment is possible in patients with HCC during
pregnancy.
Conﬂict of interest statement
None.Funding
None.
 –  O
1 al of S
E
o
A
d
L
w
s
m
1
2
3
4CASE  REPORT
14 H.-w.  Chen et al. / International Journ
thical approval
Informed consent was obtained from the patient for publication
f this case report and accompanying images.
uthor contributions
Chen  Huan-wei along with Lai Eric C.H. and Lau Wan  Yee has
one conception and design of the study. Chen Huan-wei and
i Jie-yuan have drafted the manuscript, but Li Jie-yuan teamed
ith Huang Pei-qing and Chen Ru-fang to endeavour data acqui-
ition. Finally, Lai Eric C.H. and Lau Wan  Yee have revised the
anuscript.
5
6PEN  ACCESS
urgery Case Reports 4 (2013) 112– 114
References
. Potter JF, Schoeneman M.  Metastasis of maternal cancer to the placenta and fetus.
Cancer  1970;25:380–8.
. Lau WY,  Lai EC. Hepatocellular carcinoma: current management and recent
advances. Hepatobiliary & Pancreatic Diseases International 2008;7:237–57.
. Lai EC, Lau WY.  The continuing challenge of hepatic cancer in Asia. Surgeon
2005;3:210–5.
. Lau WY,  Leung WT,  Ho S, Lam SK, Li CY, Johnson PJ, et al. Hepatocellular car-
cinoma during pregnancy and its comparison with other pregnancy-associated
malignancies. Cancer 1995;75:2669–76.
. Choi KK, Hong YJ, Choi SB, Park YN, Choi JS, Lee WJ,  et al. Hepatocellular carci-
noma during pregnancy: is hepatocellular carcinoma more aggressive in pregnant
patients? Journal of Hepato-Biliary-Pancratic Sciences 2011;18:422–31.
. De Maria N, Manno M,  Villa E. Sex hormones and liver cancer. Molecular and
Cellular  Endocrinology 2002;193:59–63.
